Abbott Korea to stop sales of Reductil
Published: 2010-10-18 06:59:00
Updated: 2010-10-18 06:59:00
Abbott Korea said on October 14 it will suspend Korea sales of a weight- loss pill in the face of a recommendation by the Korea Food and Drug Administration that heart-related risks made the prescription drug too dangerous.
The drug agency urged a halt to sales of drugs containing sibutramine,...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
